# Cigna Group (CI)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/cigna-group/ JSON: https://steadybase.io/company/cigna-group.json Checked Nov 10, 2026. Latest filing read: Nov 5, 2026.

## Company

- Legal name: Cigna Group
- Ticker: CI (NYSE)
- SEC CIK: 0001739940
- Industry: Hospital & Medical Service Plans (SIC 6324)
- Headquarters: Bloomfield, CT
- Fiscal year ends: December 31
- SEC filer category: Large accelerated filer
- Website: thecignagroup.com
- Investor relations: https://investors.thecignagroup.com/overview/default.aspx
- LinkedIn: https://www.linkedin.com/company/the-cigna-group
- Next earnings date: Jan 28, 2027 (estimated from past 8-K timing)

## Key facts

- Revenue: $274.9B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000006/0001739940-26-000006-index.html
- Operating income: $9.2B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000006/0001739940-26-000006-index.html
- Net income: $6.0B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000006/0001739940-26-000006-index.html
- SG&A: $14.6B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000006/0001739940-26-000006-index.html
- Employees: 67,700 as of Feb 26, 2026, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000006/0001739940-26-000006-index.html
- Shares outstanding: 263,502,561 as of Oct 30, 2026 (10-Q filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000071/0001739940-26-000071-index.html
- Auditor: Pricewaterhousecoopers LLP, Hartford, Connecticut, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000006/ci-20251231.htm

## Business

The Cigna Group is a global health company committed to creating a better future for every individual and every community. Powered by our dedicated people and valued brands, we advance our mission to improve the health and vitality of those we serve by staying grounded in the needs of our customers and patients - delivering a personalized, transparent and affordable health care experience. We focus on leading the way to partner and innovate solutions for better health.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000006/ci-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $274.9B | $9.2B | $6.0B | $14.6B |
| Dec 31, 2024 | $247.1B | $9.4B | $3.4B | $14.8B |
| Dec 31, 2023 | $195.3B | $8.5B | $5.2B | $14.8B |
| Dec 31, 2022 | $180.5B | $8.4B | $6.8B | $13.2B |
| Dec 31, 2021 | $174.1B | $7.9B | $5.4B | $13.0B |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/cigna-group.json

## Officers and directors

- David Cordani, Chairman & CEO. Source: Form 4 filed May 14, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000044/0001739940-26-000044-index.htm
- Ann M. Dennison, EVP, CFO. LinkedIn: https://linkedin.com/in/ann-dennison. Source: Form 4 filed Mar 3, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000010/0001739940-26-000010-index.htm
- Jamie G. Kates, Chief Accounting Officer. LinkedIn: https://linkedin.com/in/jamie-kates-a5199327. Source: Form 4 filed Jun 16, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000047/0001739940-26-000047-index.htm
- Durga Prasad Koka, EVP, Global CIO. Source: Form 4 filed Jun 3, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000045/0001739940-26-000045-index.htm
- Andrea L. Nelson, EVP, General Counsl & Corp Sec. LinkedIn: https://linkedin.com/in/andrea-nelson-05857533. Source: Form 3 filed Apr 3, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000025/0001739940-26-000025-index.htm
- F. EVERETT NEVILLE, Executive Vice President, Strategy and Business Development. LinkedIn: https://linkedin.com/in/everett-neville1. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000006/ci-20251231.htm
- Jamie Kates, Senior Vice President and Tax and Global Chief Accounting Officer (Principal Accounting Officer). Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000006/ci-20251231.htm
- Brian C. Evanko, Board member (per proxy). Source: DEF 14A filed Mar 13, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000023/ci-20260312.htm
- Donna F. Zarcone, Board member (per proxy). Source: DEF 14A filed Mar 13, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000023/ci-20260312.htm
- Eric C. Wiseman, Board member (per proxy). Source: DEF 14A filed Mar 13, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000023/ci-20260312.htm
- Eric J. Foss, Board member (per proxy). Source: DEF 14A filed Mar 13, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000023/ci-20260312.htm
- George Kurian, Board member (per proxy). Source: DEF 14A filed Mar 13, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000023/ci-20260312.htm
- Kathleen M. Mazzarella, Board member (per proxy). Source: DEF 14A filed Mar 13, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000023/ci-20260312.htm
- Kimberly A. Ross, Board member (per proxy). Source: DEF 14A filed Mar 13, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000023/ci-20260312.htm
- Mark B. McClellan, M.D., Ph.D., Board member (per proxy). Source: DEF 14A filed Mar 13, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000023/ci-20260312.htm
- Michael J. Hennigan, Board member (per proxy). Source: DEF 14A filed Mar 13, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000023/ci-20260312.htm
- Neesha Hathi, Board member (per proxy). Source: DEF 14A filed Mar 13, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000023/ci-20260312.htm
- Philip O. Ozuah, M.D., Ph.D., Board member (per proxy). Source: DEF 14A filed Mar 13, 2026, https://www.sec.gov/Archives/edgar/data/1739940/000173994026000023/ci-20260312.htm

## Recent 8-K events

- Nov 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1739940/000114036126042030/ef20084818_8k.htm
- Oct 9, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1739940/000114036126039271/ef20083475_8k.htm
- Sep 30, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1739940/000114036126038056/ef20082869_8k.htm
- Jul 30, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1739940/000114036126030135/ef20078875_8k.htm
- May 13, 2026: Item 7.01, Regulation FD disclosure. Source: https://www.sec.gov/Archives/edgar/data/1739940/000114036126020906/ef20073186_8k.htm
- Apr 30, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1739940/000114036126017971/ef20071317_8k.htm
- Apr 27, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1739940/000114036126017123/ef20071227_8k.htm
- Mar 3, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1739940/000114036126007450/ef20066976_8k.htm
- Feb 27, 2026: Item 7.01, Regulation FD disclosure. Source: https://www.sec.gov/Archives/edgar/data/1739940/000114036126007049/ef20066640_8k.htm
- Feb 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1739940/000114036126003768/ef20064751_8k.htm

## Insider trades (Form 4)

- Sep 3, 2026: Everett Neville (See Remarks) sold 617 shares, about $175,259. Source: https://www.sec.gov/Archives/edgar/data/1739940/000164114226000003/0001641142-26-000003-index.htm
- Aug 18, 2026: Nicole S. Jones (See Remarks) sold 2,677 shares, about $748,516. Source: https://www.sec.gov/Archives/edgar/data/1739940/000149266326000003/0001492663-26-000003-index.htm
- Aug 4, 2026: Nicole S. Jones (See Remarks) sold 19,436 shares, about $5.4M. Source: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000067/0001739940-26-000067-index.htm
- Jun 12, 2026: Jamie G. Kates (Chief Accounting Officer) sold 899 shares, about $268,450. Source: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000047/0001739940-26-000047-index.htm
- May 12, 2026: David Cordani (Chairman & CEO) sold 201,878 shares, about $59.1M. Source: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000044/0001739940-26-000044-index.htm
- Mar 2, 2026: Everett Neville (See Remarks) sold 1,719 shares, about $496,636. Source: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000016/0001739940-26-000016-index.htm
- Mar 2, 2026: Nicole S. Jones (See Remarks) sold 2,307 shares, about $666,515. Source: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000014/0001739940-26-000014-index.htm
- Nov 3, 2025: David Cordani (Chairman & CEO) bought 4,134 shares, about $999,932. Source: https://www.sec.gov/Archives/edgar/data/1739940/000131875125000004/0001318751-25-000004-index.htm
- Oct 3, 2025: Brian C. Evanko (See Remarks) sold 5,368 shares, about $1.6M. Source: https://www.sec.gov/Archives/edgar/data/1739940/000173994025000032/0001739940-25-000032-index.htm
- Aug 15, 2025: Nicole S. Jones (See Remarks) sold 28,526 shares, about $8.6M. Source: https://www.sec.gov/Archives/edgar/data/1739940/000122520825007353/0001225208-25-007353-index.htm

## What management said

- "Our vision for The Cigna Group’s next chapter of profitable growth is grounded in delivering greater value and personalized experiences for our customers, with three priorities : driving core growth, leveraging our distinct capabilities, and executing with discipline" Brian Evanko, President and Chief Executive Officer of The Cigna Group (8-K filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1739940/000114036126042030/ef20084818_ex99-1.htm

## Latest filings

- 8-K filed Oct 9, 2026: https://www.sec.gov/Archives/edgar/data/1739940/000114036126039271/ef20083475_8k.htm
- 10-K filed Feb 26, 2026: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000006/ci-20251231.htm
- 10-Q filed Jul 30, 2026: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000065/ci-20260630.htm
- DEF 14A filed Mar 13, 2026: https://www.sec.gov/Archives/edgar/data/1739940/000173994026000023/ci-20260312.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/